Real-World Patient Characteristics and Treatment Outcomes for Multiple Myeloma in Dreamm-7 and Dreamm-8 Cohorts in Finland
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-209552
Abstract: Introduction: Belantamab mafodotin (belamaf) is a novel treatment option for advanced multiple myeloma (MM), for which numerous clinical trials are ongoing. This population-based study aimed to describe the characteristics and treatment outcomes of MM patients,… read more here.
Keywords: dreamm; treatment; like cohort; dreamm dreamm ... See more keywords
Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials
Sign Up to like & getrecommendations! Published in 2025 at "Blood Advances"
DOI: 10.1182/bloodadvances.2025016949
Abstract: Key Points • Dose modifications in DREAMM-7 and DREAMM-8 led to less frequent belamaf dosing in later periods of treatment.• Ocular events were managed by belamaf dose modifications, which allowed for continuation of treatment and… read more here.
Keywords: dreamm; modification belantamab; efficacy; mafodotin dosing ... See more keywords